Phase II results suggest targeted therapy is effective for moderate to severe ulcerative colitis
An international placebo-controlled study led by Cedars-Sinai suggests that a targeted drug therapy that was developed by researchers at Cedars-Sinai is safe and effective at helping people with moderate to severe ulcerative ...
Sep 26, 2024
0
36